SVA

Sinovac Biotech, Ltd
SVA

Overview Fund Activity
Delisted

SVA was delisted on the 22nd of February, 2019.

Back to rankings

45 hedge funds and large institutions have $62.3M invested in Sinovac Biotech, Ltd in 2014 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 16 increasing their positions, 20 reducing their positions, and 7 closing their positions.

Holders
45
Holders Change
-5
Holders Change %
-10%
% of All Funds
1.31%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
16
Reduced
20
Closed
7
Calls
$65K
Puts
$150K
Net Calls
-$85K
Net Calls Change
+$455K

Top Buyers

1
O
1
OrbiMed
New York
$13.6M
2
PRCM
2
Pine River Capital Management
Minnesota
$5.27M
3
Wellington Management Group
3
Wellington Management Group
Massachusetts
$20.5M
4
Morgan Stanley
4
Morgan Stanley
New York
$853K
5
Renaissance Technologies
5
Renaissance Technologies
New York
$6.09M

Top Sellers

1
DSA
1
Davis Selected Advisers
Arizona
$0
2
VAM
2
Visium Asset Management
New York
$0
3
PAMU
3
Pictet Asset Management (UK)
United Kingdom
$1.28M
4
BIM
4
Bogle Investment Management
Massachusetts
$0
5
HighTower Advisors
5
HighTower Advisors
Illinois
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
WRM
51
Westport Resources Management
Connecticut
– -$60K -10,600 Closed
PCM
52
Prelude Capital Management
New York
– -$28K -5,000 Closed
1 2
3